These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 6602841)
1. Effects of neonatal anti-delta antibody treatment on the murine immune system. II. Functional capacity of a stable sIgM+sIa+sIgD- B cell population. Metcalf ES; Mond JJ; Finkelman FD J Immunol; 1983 Aug; 131(2):601-5. PubMed ID: 6602841 [TBL] [Abstract][Full Text] [Related]
2. Effects of neonatal anti-delta antibody treatment on the murine immune system. I. Suppression of development of surface IgD+ B cells and expansion of a surface IgM+ IgD- B lymphocyte population. Finkelman FD; Mond JJ; Metcalf ES J Immunol; 1983 Aug; 131(2):593-600. PubMed ID: 6602840 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the clonal diversity of the B cell repertoires in adult mice that differ in the expression of cell surface IgD. Fultz MJ; Finkelman FD; Metcalf ES Eur J Immunol; 1987 Aug; 17(8):1137-43. PubMed ID: 3113979 [TBL] [Abstract][Full Text] [Related]
4. Polyclonal activation of the murine immune system by an antibody to IgD. X. Evidence that the precursors of IgG1-secreting cells are newly generated membrane IgD+B cells rather than the B cells that are initially activated by anti-IgD antibody. Finkelman FD; Goroff DK; Fultz M; Morris SC; Holmes JM; Mond JJ J Immunol; 1990 Dec; 145(11):3562-9. PubMed ID: 2246501 [TBL] [Abstract][Full Text] [Related]
5. Polyclonal activation of the murine immune system by an antibody to IgD. IV. In vivo activation of B lymphocytes from immune defective CBA/N mice. Muul LM; Scher I; Mond JJ; Finkelman FD J Immunol; 1983 Nov; 131(5):2226-31. PubMed ID: 6605378 [TBL] [Abstract][Full Text] [Related]
6. Cell surface phenotype of lymphoid cells from normal mice and mice treated with monoclonal anti-IgD from birth. Skelly RR; Baine Y; Ahmed A; Xue B; Thorbecke GJ J Immunol; 1983 Jan; 130(1):15-8. PubMed ID: 6600173 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties. Goroff DK; Stall A; Mond JJ; Finkelman FD J Immunol; 1986 Apr; 136(7):2382-92. PubMed ID: 2419432 [TBL] [Abstract][Full Text] [Related]
8. Polyclonal activation of the murine immune system by an antibody to IgD. XI. Contribution of membrane IgD cross-linking to the generation of an in vivo polyclonal antibody response. Goroff DK; Holmes JM; Bazin H; Nisol F; Finkelman FD J Immunol; 1991 Jan; 146(1):18-25. PubMed ID: 1984444 [TBL] [Abstract][Full Text] [Related]
9. Polyclonal activation of the murine immune system by an antibody to IgD. III. Ontogeny. Muul LM; Mond JJ; Finkelman FD Eur J Immunol; 1983 Nov; 13(11):900-5. PubMed ID: 6605861 [TBL] [Abstract][Full Text] [Related]
10. Polyclonal activation of the murine immune system by an antibody to IgD. VI. Influence of doses of goat anti-mouse delta chain and normal goat IgG on B lymphocyte proliferation and differentiation. Finkelman FD; Smith J; Villacreses N; Metcalf ES Eur J Immunol; 1985 Apr; 15(4):315-20. PubMed ID: 3157578 [TBL] [Abstract][Full Text] [Related]
11. Role of antigen-specific T cell help in the generation of in vivo antibody responses. II. Sustained antigen-specific T cell help is required to induce a specific antibody response. Finkelman FD; Villacreses N; Holmes JM J Immunol; 1992 Dec; 149(12):3845-50. PubMed ID: 1281191 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of a surface antigen recognized by a monoclonal antibody, J11d, on unprimed and primed B cells. Pillai PS; Reynolds SD; Chace JH; Scott DW J Immunol; 1986 Aug; 137(3):791-7. PubMed ID: 3487587 [TBL] [Abstract][Full Text] [Related]
13. Endogenous expression of delta on the surface of WEHI-231. Characterization of its expression and signaling properties. Haggerty HG; Wechsler RJ; Lentz VM; Monroe JG J Immunol; 1993 Nov; 151(9):4681-93. PubMed ID: 8409428 [TBL] [Abstract][Full Text] [Related]
14. Polyclonal activation of the murine immune system by an antibody to IgD. VIII. Stimulation of IgD secretion. Mountz JD; Smith J; Snapper CM; Mushinski JF; Finkelman FD J Immunol; 1987 Oct; 139(7):2172-8. PubMed ID: 3498752 [TBL] [Abstract][Full Text] [Related]
15. In vivo generation and function of B cells in the presence of a monoclonal anti-IgM antibody: implications for B cell tolerance. Gause A; Yoshida N; Kappen C; Rajewsky K Eur J Immunol; 1987 Jul; 17(7):981-90. PubMed ID: 3497044 [TBL] [Abstract][Full Text] [Related]
16. Development of B lymphocytes in the mouse; studies of the frequency and distribution of surface IgM and IgD in normal and immune-defective CBA/N F1 mice. Scher I; Berning AK; Kessler S; Finkelman FD J Immunol; 1980 Oct; 125(4):1686-93. PubMed ID: 6997384 [TBL] [Abstract][Full Text] [Related]
17. sIgD-negative B cells from neonatal mice do not respond to the thymus-independent antigen TNP-BA in limiting dilution cultures. McFadden SF; Vitetta ES J Immunol; 1984 Apr; 132(4):1717-21. PubMed ID: 6607945 [TBL] [Abstract][Full Text] [Related]
18. Rapid stimulation of large specific antibody responses with conjugates of antigen and anti-IgD antibody. Lees A; Morris SC; Thyphronitis G; Holmes JM; Inman JK; Finkelman FD J Immunol; 1990 Dec; 145(11):3594-600. PubMed ID: 2246504 [TBL] [Abstract][Full Text] [Related]
19. Functional studies on B cell hybridomas with B cell surface antigens. II. Ia molecules on the cell membrane and the differentiative response to anti-mu antibody. Hamano T; Leiserson WM; Asofsky R J Immunol; 1983 Jul; 131(1):98-102. PubMed ID: 6408183 [TBL] [Abstract][Full Text] [Related]
20. B cells from M167 mu kappa transgenic mice fail to proliferate after stimulation with soluble anti-Ig antibodies. A model for antigen-induced B cell anergy. Sieckmann DG; Holmes K; Hornbeck P; Martin E; Guelde G; Bondada S; Longo DL; Kenny JJ J Immunol; 1994 May; 152(10):4873-83. PubMed ID: 8176209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]